3. Storandt M, Grant EA, Miller JP, Morris JC. Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI. Neurology 2006;67:467-473.
6. Mazzeo S, Santangelo R, Bernasconi MP, Cecchetti G, Fiorino A, Pinto P, et al. Combining cerebrospinal fluid biomarkers and neuropsychological assessment: a simple and cost-effective algorithm to predict the progression from mild cognitive impairment to alzheimer’s disease dementia. J Alzheimers Dis 2016;54:1495-1508.
8. Gallucci M, Di Battista ME, Battistella G, Falcone C, Bisiacchi PS, Di Giorgi E. Neuropsychological tools to predict conversion from amnestic mild cognitive impairment to dementia. The TREDEM Registry. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 2018;25:550-560.
9. Gothlin M, Eckerstrom M, Rolstad S, Wallin A, Nordlund A. Prognostic accuracy of mild cognitive impairment subtypes at different cut-off levels. Dement Geriatr Cogn Disord 2017;43:330-341.
15. Blacker D, Lee H, Muzikansky A, Martin EC, Tanzi R, McArdle JJ, et al. Neuropsychological measures in normal individuals that predict subsequent cognitive decline. Arch Neurol 2007;64:862-871.
17. Chen Y, Denny KG, Harvey D, Farias ST, Mungas D, DeCarli C, et al. Progression from normal cognition to mild cognitive impairment in a diverse clinic-based and community-based elderly cohort. Alzheimers Dement 2017;13:399-405.
20. Seo EH, Kim H, Lee KH, Choo IH. Altered executive function in premild cognitive impairment. J Alzheimers Dis 2016;54:933-940.
21. Reisberg B, Prichep L, Mosconi L, John ER, Glodzik-Sobanska L, Boksay I, et al. The pre-mild cognitive impairment, subjective cognitive impairment stage of Alzheimer’s disease. Alzheimers Dement 2008;4(1 Suppl 1):S98-S108.
24. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001;58:397-405.
25. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol 1987;149:351-356.
26. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572.
27. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
28. Kang SJ, Choi SH, Lee BH, Kwon JC, Na DL, Han SH, et al. The Reliability and Validity of the Korean Instrumental Activities of Daily Living (K-IADL). J Korean Neurol Assoc 2002;20:8-14.
29. Yang DW, Cho BL, Chey JY, Kim SY, Kim BS. The Development and Validation of Korean Dementia Screening Questionnaire (KDSQ). J Korean Neurol Assoc 2002;20:135-141.
30. Youn JC, Kim KW, Lee DY, Jhoo JH, Lee SB, Park JH, et al. Development of the subjective memory complaints questionnaire. Dement Geriatr Cogn Disord 2009;27:310-317.
32. Kang Y, Na D, Hahn S. Seoul Neuropsychological Screening Battery. Incheon: Human Brain Research & Consulting Co; 2003.
33. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al. Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240-246.
34. Watanabe K, Ogino T, Nakano K, Hattori J, Kado Y, Sanada S, et al. The Rey-Osterrieth Complex Figure as a measure of executive function in childhood. Brain Dev 2005;27:564-569.
35. Somerville J, Tremont G, Stern RA. The Boston Qualitative Scoring System as a measure of executive functioning in Rey-Osterrieth Complex Figure performance. J Clin Exp Neuropsychol 2000;22:613-621.
36. Ogino T, Watanabe K, Nakano K, Kado Y, Morooka T, Takeuchi A, et al. Predicting executive function task scores with the Rey-Osterrieth Complex Figure. Brain Dev 2009;31:52-57.